Department of Radiology, Huashan Hospital, Fudan University, Shanghai, P.R. China.
Department of Biomedical Engineering, Fourth Military Medical University, Xi'an, Shaanxi, P.R. China.
J Magn Reson Imaging. 2019 Mar;49(3):808-817. doi: 10.1002/jmri.26240. Epub 2018 Sep 8.
Noninvasive detection of isocitrate dehydrogenase 1 mutation (IDH1(+)) and loss of nuclear alpha thalassemia/mental retardation syndrome X-linked expression ((ATRX(-)) are clinically meaningful for molecular stratification of low-grade gliomas (LGGs).
To study a radiomic approach based on multiparametric MR for noninvasively determining molecular status of IDH1(+) and ATRX(-) in patients with LGG.
Retrospective, radiomics.
Fifty-seven LGG patients with IDH1(+) (n = 36 with 19 ATRX(-) and 17 ATRX(+) patients) and IDH1(-) (n = 21).
FIELD STRENGTH/SEQUENCE: 3.0T MRI / 3D arterial spin labeling (3D-ASL), T /fluid-attenuated inversion recovery (T FLAIR), and diffusion-weighted imaging (DWI).
In all, 265 high-throughput radiomic features were extracted on each tumor volume of interest from T FLAIR and the other three parametric maps of ASL-derived cerebral blood flow (CBF), DWI-derived apparent diffusion coefficient (ADC), and exponential ADC (eADC). Optimal feature subsets were selected as using the support vector machine with a recursive feature elimination algorithm (SVM-RFE). Receiver operating characteristic curve (ROC) analysis was employed to assess the efficiency for identifying the IDH1(+) and ATRX(-) status.
Student's t-test, chi-square test, and Fisher's exact test were applied to confirm whether intergroup significant differences exist between molecular subtypes decided by IDH1 and ATRX.
Optimal SVM predictive models of IDH1(+) and ATRX(-) were established using 28 features from T Flair, ADC, eADC, and CBF and six features from T Flair, ADC, and CBF. The accuracies/AUCs/sensitivity/specifity/PPV/NPV of predicting IDH1(+) in LGG were 94.74%/0.931/100%/85.71%/92.31%/100%, and those of predicting ATRX(-) in LGG with IDH1(+) were 91.67%/0.926/94.74%/88.24%/90.00%/93.75%, respectively.
Using the optimal texture features extracted from multiple MR sequences or parametric maps, a promising stratifying strategy was acquired for predicting molecular subtypes of IDH1 and ATRX in LGGs.
3 Technical Efficacy Stage: 2 J. Magn. Reson. Imaging 2019;49:808-817.
对异柠檬酸脱氢酶 1 突变(IDH1(+))和 X 连锁α-地中海贫血/智力低下综合征核表达缺失(ATRX(-))的非侵入性检测对低级别胶质瘤(LGG)的分子分层具有重要的临床意义。
研究一种基于多参数磁共振的放射组学方法,无创性确定 LGG 患者 IDH1(+)和 ATRX(-)的分子状态。
回顾性、放射组学研究。
57 例 IDH1(+)(n=36,其中 19 例 ATRX(-)和 17 例 ATRX(+))和 IDH1(-)(n=21)LGG 患者。
场强/序列: 3.0T MRI/三维动脉自旋标记(3D-ASL)、T/液体衰减反转恢复(T FLAIR)和弥散加权成像(DWI)。
在每个感兴趣的肿瘤容积上,总共从 T FLAIR 和其他三个参数图(ASL 衍生的脑血流(CBF)、DWI 衍生的表观弥散系数(ADC)和指数 ADC(eADC))中提取了 265 个高通量放射组学特征。使用支持向量机与递归特征消除算法(SVM-RFE)选择最佳特征子集。采用受试者工作特征曲线(ROC)分析评估识别 IDH1(+)和 ATRX(-)状态的效率。
学生 t 检验、卡方检验和 Fisher 精确检验用于确认分子亚型由 IDH1 和 ATRX 决定的组间是否存在显著差异。
使用来自 T Flair、ADC、eADC 和 CBF 的 28 个特征以及来自 T Flair、ADC 和 CBF 的 6 个特征,建立了用于预测 IDH1(+)和 ATRX(-)的最佳 SVM 预测模型。LGG 中预测 IDH1(+)的准确性/AUC/敏感性/特异性/PPV/NPV 分别为 94.74%/0.931/100%/85.71%/92.31%/100%,LGG 中 IDH1(+)伴 ATRX(-)的预测准确性/AUC/敏感性/特异性/PPV/NPV 分别为 91.67%/0.926/94.74%/88.24%/90.00%/93.75%。
使用来自多个 MR 序列或参数图的最佳纹理特征,可以获得一种有前途的分层策略,用于预测 LGG 中 IDH1 和 ATRX 的分子亚型。
3 技术功效阶段: 2 J. Magn. Reson. Imaging 2019;49:808-817.